FORM N-PX PROXY VOTING RECORD
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | COLUMN 9 | COLUMN 10 | COLUMN 11 | COLUMN 12 | COLUMN 13 | COLUMN 14 | COLUMN 15 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAME OF ISSUER |
CUSIP | ISIN | FIGI | MEETING DATE | VOTE DESCRIPTION | VOTE CATEGORY | DESCRIPTION OF OTHER CATEGORY | VOTE SOURCE | SHARES VOTED | SHARES ON LOAN | DETAILS OF VOTE | MANAGER NUMBER | SERIES ID | OTHER INFO | ||
| HOW VOTED | SHARES VOTED | FOR OR AGAINST MANAGEMENT | ||||||||||||||
| ABBVIE INC. | 00287Y109 | US00287Y1091 | - | 05/03/2024 | Say on Pay - An advisory vote on the approval of executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | - | 81026 | 0 | FOR |
81026 |
FOR |
- | - | |
| ABBVIE INC. | 00287Y109 | US00287Y1091 | - | 05/03/2024 | Say When on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | - | 81026 | 0 | FOR |
81026 |
FOR |
- | - | |
| ACADIA HEALTHCARE COMPANY, INC. | 00404A109 | US00404A1097 | - | 05/23/2024 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 327471 | 0 | FOR |
327471 |
FOR |
- | - | |
| ACADIA HEALTHCARE COMPANY, INC. | 00404A109 | US00404A1097 | - | 05/23/2024 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 2721 | 0 | FOR |
2721 |
FOR |
- | - | |
| ACADIA HEALTHCARE COMPANY, INC. | 00404A109 | US00404A1097 | - | 05/23/2024 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 74892 | 0 | FOR |
74892 |
FOR |
- | - | |
| ALIGN TECHNOLOGY, INC. | 016255101 | US0162551016 | - | 05/22/2024 | ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 51550 | 0 | FOR |
51550 |
FOR |
- | - | |
| ALIGN TECHNOLOGY, INC. | 016255101 | US0162551016 | - | 05/22/2024 | ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 51528 | 0 | FOR |
51528 |
FOR |
- | - | |
| ALIGN TECHNOLOGY, INC. | 016255101 | US0162551016 | - | 05/22/2024 | ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3477 | 0 | FOR |
3477 |
FOR |
- | - | |
| ALIGN TECHNOLOGY, INC. | 016255101 | US0162551016 | - | 05/22/2024 | ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3754 | 0 | FOR |
3754 |
FOR |
- | - | |
| APELLIS PHARMACEUTICALS INC. | 03753U106 | US03753U1060 | - | 06/05/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 24604 | 0 | AGAINST |
24604 |
AGAINST |
- | - | |
| APELLIS PHARMACEUTICALS INC. | 03753U106 | US03753U1060 | - | 06/05/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 46187 | 0 | AGAINST |
46187 |
AGAINST |
- | - | |
| APELLIS PHARMACEUTICALS INC. | 03753U106 | US03753U1060 | - | 06/05/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 194175 | 0 | AGAINST |
194175 |
AGAINST |
- | - | |
| APELLIS PHARMACEUTICALS INC. | 03753U106 | US03753U1060 | - | 06/05/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 203614 | 0 | AGAINST |
203614 |
AGAINST |
- | - | |
| APELLIS PHARMACEUTICALS INC. | 03753U106 | US03753U1060 | - | 06/05/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 6421 | 0 | AGAINST |
6421 |
AGAINST |
- | - | |
| BROOKDALE SENIOR LIVING INC. | 112463104 | US1124631045 | - | 06/18/2024 | Advisory approval of named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 74591 | 0 | FOR |
74591 |
FOR |
- | - | |
| BROOKDALE SENIOR LIVING INC. | 112463104 | US1124631045 | - | 06/18/2024 | Advisory approval of named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1913217 | 0 | FOR |
1913217 |
FOR |
- | - | |
| BROOKDALE SENIOR LIVING INC. | 112463104 | US1124631045 | - | 06/18/2024 | Advisory approval of named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 422718 | 0 | FOR |
422718 |
FOR |
- | - | |
| BROOKDALE SENIOR LIVING INC. | 112463104 | US1124631045 | - | 06/18/2024 | Advisory approval of named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 455262 | 0 | FOR |
455262 |
FOR |
- | - | |
| BROOKDALE SENIOR LIVING INC. | 112463104 | US1124631045 | - | 06/18/2024 | Advisory approval of named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 11429 | 0 | FOR |
11429 |
FOR |
- | - | |
| BRUKER CORPORATION | 116794108 | US1167941087 | - | 05/30/2024 | Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 40 | 0 | FOR |
40 |
FOR |
- | - | |
| BRUKER CORPORATION | 116794108 | US1167941087 | - | 05/30/2024 | Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 44 | 0 | FOR |
44 |
FOR |
- | - | |
| BRUKER CORPORATION | 116794108 | US1167941087 | - | 05/30/2024 | Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 169218 | 0 | FOR |
169218 |
FOR |
- | - | |
| BRUKER CORPORATION | 116794108 | US1167941087 | - | 05/30/2024 | Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 169299 | 0 | FOR |
169299 |
FOR |
- | - | |
| BRUKER CORPORATION | 116794108 | US1167941087 | - | 05/30/2024 | Approval on an advisory basis of the 2023 compensation of our named executive officers, as discussed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3452 | 0 | FOR |
3452 |
FOR |
- | - | |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 40550 | 0 | FOR |
40550 |
FOR |
- | - | |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1629 | 0 | FOR |
1629 |
FOR |
- | - | |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 342 | 0 | FOR |
342 |
FOR |
- | - | |
| CYTOKINETICS, INCORPORATED | 23282W605 | US23282W6057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 369 | 0 | FOR |
369 |
FOR |
- | - | |
| DEXCOM, INC. | 252131107 | US2521311074 | - | 05/22/2024 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 140645 | 0 | FOR |
140645 |
FOR |
- | - | |
| DEXCOM, INC. | 252131107 | US2521311074 | - | 05/22/2024 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1993 | 0 | FOR |
1993 |
FOR |
- | - | |
| DEXCOM, INC. | 252131107 | US2521311074 | - | 05/22/2024 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 2152 | 0 | FOR |
2152 |
FOR |
- | - | |
| DEXCOM, INC. | 252131107 | US2521311074 | - | 05/22/2024 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 171265 | 0 | FOR |
171265 |
FOR |
- | - | |
| ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | US28414H1032 | - | 05/30/2024 | Advisory vote on the compensation of the company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 457079 | 0 | FOR |
457079 |
FOR |
- | - | |
| ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | US28414H1032 | - | 05/30/2024 | Advisory vote on the compensation of the company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 100992 | 0 | FOR |
100992 |
FOR |
- | - | |
| ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | US28414H1032 | - | 05/30/2024 | Advisory vote on the compensation of the company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 108721 | 0 | FOR |
108721 |
FOR |
- | - | |
| ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | US28414H1032 | - | 05/30/2024 | Advisory vote on the compensation of the company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 120168 | 0 | FOR |
120168 |
FOR |
- | - | |
| ELANCO ANIMAL HEALTH INCORPORATED | 28414H103 | US28414H1032 | - | 05/30/2024 | Advisory vote on the compensation of the company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 150772 | 0 | FOR |
150772 |
FOR |
- | - | |
| EXACT SCIENCES CORPORATION | 30063P105 | US30063P1057 | - | 06/13/2024 | To approve, on an advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1239 | 0 | FOR |
1239 |
FOR |
- | - | |
| EXACT SCIENCES CORPORATION | 30063P105 | US30063P1057 | - | 06/13/2024 | To approve, on an advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1334 | 0 | FOR |
1334 |
FOR |
- | - | |
| EXACT SCIENCES CORPORATION | 30063P105 | US30063P1057 | - | 06/13/2024 | To approve, on an advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 32839 | 0 | FOR |
32839 |
FOR |
- | - | |
| EXACT SCIENCES CORPORATION | 30063P105 | US30063P1057 | - | 06/13/2024 | To approve, on an advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 34448 | 0 | FOR |
34448 |
FOR |
- | - | |
| EXACT SCIENCES CORPORATION | 30063P105 | US30063P1057 | - | 06/13/2024 | To approve, on an advisory basis, the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 54896 | 0 | FOR |
54896 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote to approve compensation for our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 14425 | 0 | FOR |
14425 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote on the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 14425 | 0 | FOR |
14425 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote to approve compensation for our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3029 | 0 | FOR |
3029 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote on the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3029 | 0 | FOR |
3029 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote to approve compensation for our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3297 | 0 | FOR |
3297 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote on the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 3297 | 0 | FOR |
3297 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote to approve compensation for our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 19890 | 0 | FOR |
19890 |
FOR |
- | - | |
| FORTREA HOLDINGS | 34965K107 | US34965K1079 | - | 05/14/2024 | Advisory vote on the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 19890 | 0 | FOR |
19890 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 158823 | 0 | FOR |
158823 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 158823 | 0 | FOR |
158823 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 21104 | 0 | FOR |
21104 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 21104 | 0 | FOR |
21104 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 151461 | 0 | FOR |
151461 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 151461 | 0 | FOR |
151461 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 33466 | 0 | FOR |
33466 |
FOR |
- | - | |
| GLAUKOS CORPORATION | 377322102 | US3773221029 | - | 05/30/2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 33466 | 0 | FOR |
33466 |
FOR |
- | - | |
| ILLUMINA, INC. | 452327109 | US4523271090 | - | 05/16/2024 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 372 | 0 | FOR |
372 |
FOR |
- | - | |
| ILLUMINA, INC. | 452327109 | US4523271090 | - | 05/16/2024 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 402 | 0 | FOR |
402 |
FOR |
- | - | |
| ILLUMINA, INC. | 452327109 | US4523271090 | - | 05/16/2024 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 11494 | 0 | FOR |
11494 |
FOR |
- | - | |
| ILLUMINA, INC. | 452327109 | US4523271090 | - | 05/16/2024 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 88654 | 0 | FOR |
88654 |
FOR |
- | - | |
| INTUITIVE SURGICAL, INC. | 46120E602 | US46120E6023 | - | 04/25/2024 | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 36013 | 0 | FOR |
36013 |
FOR |
- | - | |
| INTUITIVE SURGICAL, INC. | 46120E602 | US46120E6023 | - | 04/25/2024 | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 4478 | 0 | FOR |
4478 |
FOR |
- | - | |
| NEUROCRINE BIOSCIENCES, INC. | 64125C109 | US64125C1099 | - | 05/22/2024 | Advisory vote on the compensation paid to the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 17108 | 0 | FOR |
17108 |
FOR |
- | - | |
| NEUROCRINE BIOSCIENCES, INC. | 64125C109 | US64125C1099 | - | 05/22/2024 | Advisory vote on the compensation paid to the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 18623 | 0 | FOR |
18623 |
FOR |
- | - | |
| OSCAR HEALTH, INC. | 687793109 | US6877931096 | - | 06/06/2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 111853 | 0 | AGAINST |
111853 |
AGAINST |
- | - | |
| OSCAR HEALTH, INC. | 687793109 | US6877931096 | - | 06/06/2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 470247 | 0 | AGAINST |
470247 |
AGAINST |
- | - | |
| OSCAR HEALTH, INC. | 687793109 | US6877931096 | - | 06/06/2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 103902 | 0 | AGAINST |
103902 |
AGAINST |
- | - | |
| OSCAR HEALTH, INC. | 687793109 | US6877931096 | - | 06/06/2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 155115 | 0 | AGAINST |
155115 |
AGAINST |
- | - | |
| SCHRODINGER, INC. | 80810D103 | US80810D1037 | - | 06/18/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 179891 | 0 | FOR |
179891 |
FOR |
- | - | |
| SCHRODINGER, INC. | 80810D103 | US80810D1037 | - | 06/18/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 56590 | 0 | FOR |
56590 |
FOR |
- | - | |
| SCHRODINGER, INC. | 80810D103 | US80810D1037 | - | 06/18/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 263134 | 0 | FOR |
263134 |
FOR |
- | - | |
| SCHRODINGER, INC. | 80810D103 | US80810D1037 | - | 06/18/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1684 | 0 | FOR |
1684 |
FOR |
- | - | |
| SCHRODINGER, INC. | 80810D103 | US80810D1037 | - | 06/18/2024 | Approval of an advisory vote on executive compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1813 | 0 | FOR |
1813 |
FOR |
- | - | |
| SYNDAX PHARMACEUTICALS, INC | 87164F105 | US87164F1057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2024 proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 74134 | 0 | AGAINST |
74134 |
AGAINST |
- | - | |
| SYNDAX PHARMACEUTICALS, INC | 87164F105 | US87164F1057 | - | 05/15/2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2024 proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 8367 | 0 | AGAINST |
8367 |
AGAINST |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 319149 | 0 | FOR |
319149 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 319149 | 0 | FOR |
319149 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1004694 | 0 | FOR |
1004694 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1004694 | 0 | FOR |
1004694 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 211072 | 0 | FOR |
211072 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 211072 | 0 | FOR |
211072 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 229771 | 0 | FOR |
229771 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 229771 | 0 | FOR |
229771 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 246698 | 0 | FOR |
246698 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 246698 | 0 | FOR |
246698 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 54505 | 0 | FOR |
54505 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 54505 | 0 | FOR |
54505 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 58708 | 0 | FOR |
58708 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 58708 | 0 | FOR |
58708 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 81410 | 0 | FOR |
81410 |
FOR |
- | - | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | 881624209 | US8816242098 | - | 06/06/2024 | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 81410 | 0 | FOR |
81410 |
FOR |
- | - | |
| WEST PHARMACEUTICAL SERVICES, INC. | 955306105 | US9553061055 | - | 04/23/2024 | Advisory vote to approve named executive officer compensation. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 269 | 0 | FOR |
269 |
FOR |
- | - | |
[Repeat as Necessary]